Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IFRX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

InflaRx N.V. stock price up 1.17% on Tuesday
(Updated on Jul 02, 2024)

Buy or Hold candidate since Jun 24, 2024 Gain 3.59% PDF

The InflaRx N.V. stock price gained 1.17% on the last trading day (Tuesday, 2nd Jul 2024), rising from $1.71 to $1.73. During the last trading day the stock fluctuated 5.42% from a day low at $1.66 to a day high of $1.75. The price has risen in 6 of the last 10 days and is up by 14.57% over the past 2 weeks. Volume fell on the last day by -17 thousand shares and in total, 63 thousand shares were bought and sold for approximately $108.84 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $1.75 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 15.88% during the next 3 months and, with a 90% probability hold a price between $1.52 and $2.03 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IFRX Signals & Forecast

The InflaRx N.V. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.68 and $1.54. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 28, 2024, and so far it has fallen -0.575%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for InflaRx N.V. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.63 and $1.52. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, InflaRx N.V. finds support just below today's level at $1.63. If this is broken, then the next support from accumulated volume will be at $1.52 and $1.43.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0900 between high and low, or 5.42%. For the last week the stock has had daily average volatility of 6.88%.

Our recommended stop-loss: $1.67 (-3.28%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 22 days ago.)

Trading Expectations (IFRX) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect InflaRx N.V. to open at $1.71, and during the day (based on 14 day Average True Range), to move between $1.60 and $1.86, which gives a possible trading interval of +/-$0.126 (+/-7.29%) up or down from last closing price. If InflaRx N.V. takes out the full calculated possible swing range there will be an estimated 14.59% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.74 (0.58%) than the support at $1.63 (5.78%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is InflaRx N.V. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for InflaRx N.V. stock to perform well in the short-term.

Current score: 2.667 Buy Candidate Unchanged

Predicted Opening Price for InflaRx N.V. of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$1.71 ( 0.96%) $1.73

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IFRX

Fibonacci Support & Resistance Levels

Level Price
R3 1.80 4.24%
R2 1.77 2.25%
R1 1.75 1.02%
Price 1.73
S1 1.68 -2.95%
S2 1.66 -4.18%
S3 1.62 -6.17%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 1.74 0.578%
Price 1.73
S1 1.63 -5.78%
S2 1.52 -12.14%
S3 1.43 -17.34%

FAQ

What is the symbol for InflaRx N.V. Stock and on which exchange is it traded?
The symbol for InflaRx N.V. is IFRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell InflaRx N.V. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for InflaRx N.V. stock to perform well in the short-term.

How to buy InflaRx N.V. Stock?
InflaRx N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy InflaRx N.V. Stock.

What's the current price of InflaRx N.V. Stock?
As of the end of day on the Jul 02, 2024, the price of an InflaRx N.V. (IFRX) share was $1.73.

What is the 52-week high and low for InflaRx N.V. Stock?
The 52-week high for InflaRx N.V. Stock is $4.50 and the 52-week low is $1.14.

What is the market capitalization of InflaRx N.V. Stock?
As of the Jul 02, 2024, the market capitalization of InflaRx N.V. is 100.69M.

When is the next earnings date for InflaRx N.V.?
The upcoming earnings date for InflaRx N.V. is Aug 08, 2024.
Click to get the best stock tips daily for free!

About InflaRx N.V.

InflaRx N.V. InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III c... IFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT